| ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
| ADIPOQ |
Q15848
|
adiponectin, C1Q and collagen domain containing
|
|
4.6E-09 |
0.376 |
0.885 |
| AGER |
Q15109
|
advanced glycosylation end-product specific receptor
|
Receptor
|
6.4E-16 |
0.420 |
0.885 |
| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| CABIN1 |
Q9Y6J0
|
calcineurin binding protein 1
|
Enzyme modulator
|
3.3E-17 |
0.536 |
0.846 |
| CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
| CCL21 |
O00585
|
C-C motif chemokine ligand 21
|
Signaling
|
3.6E-02 |
0.502 |
0.769 |
| CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
| CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
| CHI3L1 |
P36222
|
chitinase 3 like 1
|
|
1.1E-05 |
0.419 |
0.885 |
| CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
| CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
| DMD |
P11532
|
dystrophin
|
|
1.00 |
0.423 |
0.923 |
| FGF21 |
Q9NSA1
|
fibroblast growth factor 21
|
Signaling
|
2.9E-02 |
0.485 |
0.769 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| HSPD1 |
P10809
|
heat shock protein family D (Hsp60) member 1
|
|
0.99 |
0.432 |
0.808 |
| IFIH1 |
Q9BYX4
|
interferon induced with helicase C domain 1
|
|
7.0E-44 |
0.471 |
0.808 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
| IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
| IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |
| IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |